Certain subsets of these tumour-infiltrating Breg cells can upregulate PD-1 expression in response to signaling from cancer cells, promoting T-cell dysfunction via IL-10 [76] or, independently of IL-10, via PD-L1 [77]. The gene discussed is IL10; the disease is cancer.